Citadel Advisors’s Prestige Consumer Healthcare PBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-100
Closed -$8.6K 14400
2025
Q1
$8.6K Sell
100
-100
-50% -$8.2K ﹤0.01% 13634
2024
Q4
$15.6K Sell
200
-6,100
-97% -$474K ﹤0.01% 13341
2024
Q3
$454K Buy
6,300
+4,900
+350% +$347K ﹤0.01% 8481
2024
Q2
$96.4K Sell
1,400
-100
-7% -$6.78K ﹤0.01% 10971
2024
Q1
$109K Sell
1,500
-1,000
-40% -$66.9K ﹤0.01% 11238
2023
Q4
$153K Sell
2,500
-1,700
-40% -$101K ﹤0.01% 10350
2023
Q3
$240K Sell
4,200
-1,900
-31% -$115K ﹤0.01% 9570
2023
Q2
$363K Buy
6,100
+5,200
+578% +$311K ﹤0.01% 8636
2023
Q1
$56.4K Buy
+900
New +$56.2K ﹤0.01% 12010
2021
Q3
Sell
-23,300
Closed -$1.21M 14427
2021
Q2
$1.21M Sell
23,300
-400
-2% -$19.2K ﹤0.01% 7837
2021
Q1
$1.04M Sell
23,700
-700
-3% -$29.4K ﹤0.01% 8002
2020
Q4
$851K Buy
+24,400
New +$866K ﹤0.01% 7130
2020
Q3
Sell
-6,900
Closed -$259K 10565
2020
Q2
$259K Buy
+6,900
New +$276K ﹤0.01% 8156

Other funds holding PBH

Citadel Advisors's PBH Position: Q1 2026 in Review

Citadel Advisors reduced its Prestige Consumer Healthcare (PBH) stake by 25% in Q1 2026, selling an estimated $3.91M and leaving 183,440 shares worth $10.9M. The position accounts for ﹤0.01% of the portfolio, ranked #3136.

Citadel Advisors first reported a position in PBH in Q2 2013 and has held it in 46 quarters since. The position peaked at $15M in Q4 2025. 355 funds tracked by Wall St. Rank hold PBH as of Q1 2026.

  • Citadel Advisors held 183,440 shares of Prestige Consumer Healthcare worth $10.9M as of Q1 2026.
  • Citadel Advisors sold 60,221 Prestige Consumer Healthcare shares in Q1 2026, an estimated $3.91M.
  • Prestige Consumer Healthcare made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #3136 holding.
  • Citadel Advisors first reported a position in Prestige Consumer Healthcare in Q2 2013 and has held it in 46 quarters since.
  • Citadel Advisors's Prestige Consumer Healthcare position peaked at $15M in Q4 2025.
  • 355 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.